Form 4 Tracker
Benjamin L Palleiko

Director, CHIEF EXECUTIVE OFFICER · 10 filings · Latest: Jun 11, 2026

KalVista Pharmaceuticals, Inc.
TickerOwnerRelationshipDateTransactionCost#SharesValue ($)#Shares TotalSEC Filing
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 22, 2026
Sale
$26.7810,926$292.6K479,989
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 21, 2026
Option Exercise
23,250490,915
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 18, 2026
Sale
$26.761,129$30.2K467,665
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 17, 2026
Option Exercise
2,419468,794
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 12, 2026
Sale
$26.713,322$88.7K466,375
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMay 11, 2026
Option Exercise
7,120469,697
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERApr 17, 2026
Sale
$20.229,550$193.1K462,577
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERApr 16, 2026
Option Exercise
20,312472,127
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMar 9, 2026
Sale
$16.086,693$107.6K451,815
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERMar 6, 2026
Option Exercise
15,625458,508
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 23, 2026
Sale
$15.5710,034$156.2K442,883
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 21, 2026
Option Exercise
23,250452,917
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 18, 2026
Sale
$15.001,038$15.6K429,667
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 17, 2026
Option Exercise
2,419430,705
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 12, 2026
Sale
$15.703,354$52.7K428,286
KALV
Benjamin L PalleikoDirector, CHIEF EXECUTIVE OFFICERFeb 11, 2026
Option Exercise
7,120431,640